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Abstract
The gene that codes for the ABC transporter ABCG1 is
located in a chromosomal susceptibility region (21q22.3)
for affective disorders. Genetic variations in ABCG1 have
been associated with affective disorders in Japanese
males. In this study, we investigated the distribution of a
G2457A polymorphism in patients with affective disor-
ders, suicide attempters with various psychiatric diag-
noses and healthy subjects. We initially found a trend
towards a modest association with affective disorders in
males (p = 0.046 for allele frequencies and p = 0.046 for
AA versus GG). We conducted a replication study with
independent patients and controls. There was no asso-
ciation with affective disorders, either in the replication
or in the combined group. Furthermore, we found no
association with suicidal behavior. These findings do not
support the hypothesis that ABCG1 is a susceptibility
gene for affective disorders or suicidal behavior. 
Copyright © 2000 S. Karger AG, Basel
Introduction
The ABC transporter homologous to Drosophila white
gene (ABCG1) is a member of the ATP-binding cassette
(ABC) transporter superfamily of transmembrane per-
meases with highest levels of expression in brain, spleen
and lung. The gene is located in a chromosomal region
(21q22.3) that has been linked to affective disorders by
several investigators [1]. Hence, the ABCG1 transporter
gene might represent a good positional candidate for
affective disorders. Since 1969, when Lapin and Oxen-
krug [2] formulated the serotonin hypothesis of depres-
sion, a large body of evidence has been gathered to indi-
cate that altered serotonin metabolism might be involved
in the pathobiochemistry of affective disorders [3]. Al-
though not yet demonstrated in humans, the gene product
of ABCG1 is involved in the transport of tryptophan, the
precursor of serotonin, in Drosophila [4]. Moreover, Na-
kamura et al. [5] found an association of a G2457A poly-
morphism in the ABCG1 gene with mood disorders in
males. These lines of evidence support the notion that the
ABCG1 gene might indeed be a susceptibility gene in
affective disorders. Suicidal behavior has been widely
related to altered serotonergic transmission [3, 6]. There is
a remarkable association between low concentrations of
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5-hydroxyindoleacetic acid in the cerebrospinal fluid and
suicidal behavior within a wide range of diagnoses [7].
With regard to suicidal behavior, twin and adoption stud-
ies show a clear genetic contribution [8]. No linkage stud-
ies have been published to date, but several association
studies indicate that variations in serotonergic genes
might be associated with suicide attempts [9, 10]. Al-
though the molecular genetic findings are somehow in-
consistent, only a few studies were designed to address
this question directly. In order to test the hypothesis that
ABCG1 is a susceptibility gene for affective disorders and
suicidal behavior, we performed an association study with
a G2457A single nucleotide polymorphism at position
2457 in the 3)-UTR of the ABCG1 gene in two indepen-
dent populations of patients suffering from affective dis-
orders, and one population of patients with various psy-
chiatric diagnoses who had made a documented suicide
attempt.
Materials and Methods
Psychiatric Patients
Two groups of patients consisted of 18- to 65-year-old Caucasian
inpatients, hospitalized in the Department of Psychiatry, Ludwig-
Maximilians-University, Munich, Germany. One group had a cur-
rent or past history of suicide attempts and various psychiatric disor-
ders (n = 70; 26 males, 44 females), whereas another group had affec-
tive disorders (n = 52; 17 males, 35 females). In the latter group, 42
patients were diagnosed with unipolar major depression (14 males,
28 females) and 10 patients with bipolar disorder (3 males, 7
females). The diagnosis was established by the Structured Clinical
Interview for DSM-IV (SCID I and SCID II).
The replication sample consisted of 18- to 65-year-old Caucasian
outpatients with major depression according to DSM-IV criteria (n =
104; 25 males, 79 females) recruited from the Department of Psy-
chiatry, Johannes-Gutenberg-University, Mainz, Germany. The
diagnosis was established by the Mini International Neuropsychiat-
ric Interview [11].
Exclusion criteria for all groups included any serious medical con-
dition, mood disorders due to a general medical condition or sub-
stance abuse, dementia, and also schizophrenia and related psychotic
disorders.
Control Subjects
We randomly selected 18- to 65-year-old Caucasians from the
general population of Munich and contacted them by mail. Subjects
who responded were first screened by phone. They subsequently
filled out a detailed medical history form both for themselves and
their relatives. Psychiatric disorders of the subjects were excluded by
SCID I and SCID II, and a psychiatric diagnosis in first- and second-
degree relatives was excluded using the Family History Assessment
Module. Ninety-seven healthy control subjects (48 males, 49 fe-
males) without relevant somatic and with no psychiatric disorder
were included.
For the replication study, 18- to 65-year-old Caucasians (n = 92;
65 males, 27 females) were recruited by the Department of Psychia-
try, Johannes-Gutenberg-University, Mainz, Germany, as healthy
controls.
After written informed consent had been obtained from all sub-
jects, blood samples were collected and the distribution of a genetic
polymorphis in the ABCG1 gene was examined.
Genotyping
Genomic DNA was prepared from 10 ml blood using the Quiagen
Maxi DNA Extraction Kit. In order to assess allele and genotype fre-
quency of the A2457G transversion polymorphism in the 3) untrans-
lated region of ABCG1, PCR was performed with primer pair
HDW-l (5)-ACA GCT GGT GAT GAG AGG CT-3)) and HDW-r
(5)-AGA TGG TGT CCA CGT CTT CC-3)). The 50-Ìl reactions
contained 50 ng genomic DNA, 0.4 mM dNTPs, 50 mM KCl,
20 mM Tris-HCl (pH 8.4), 1.5 mM MgCl2, 0.3 ÌM of each primer,
and 1 U Taq polymerase (Life Technologies). Following an initial
denaturation step at 95 °C for 3 min, DNA was amplified in 35 cycles
of PCR (94 °C for 30 s, 56 °C for 30 s, 72 °C for 1 min). The final
extension step was 72 °C for 5 min; 30 Ìl of the PCR product were
digested with 5 U of HhaI (New England Biolabs), analyzed by gel
electrophoresis in a 2% agarose gel containing ethidium bromide and
visualized under UV light. When guanine is present at position 2457
in the 3)-UTR (pos. 104 of the PCR product), digestion results in two
fragments of 104 bp and 321 bp, whereas the absence of the HhaI
recognition site leaves the 425-bp PCR product intact.
Statistical Analysis
¯2 Tests were performed to compare allele and genotype frequen-
cies. Values of p ! 0.05 were considered significant, while p ! 0.1 was
viewed as indicating a trend.
Results
The distribution of genotype and allele frequencies of
the polymorphism in the ABCG1 gene in healthy con-
trols, patients with affective disorders and suicide at-
tempters is shown in table 1. The genotypic distribution
was in Hardy-Weinberg equilibrium (total controls: ¯2 =
0.332, p = 0.847; male controls: ¯2 = 0.167, p = 0.920;
female controls: ¯ 2 = 0.165, p = 0.921). In our first sample
of patients with affective disorders, we found a trend
towards higher frequencies of the G allele and GG geno-
type in males (p = 0.046 for allele frequencies, p = 0.113
for genotype frequencies and p = 0.046 for AA versus
GG), but not in females (p = 0.714 for allele and p = 0.577
for genotype frequencies) or in the total sample (p = 0.128
for allele and p = 0.216 for genotype frequencies). In order
to replicate these findings, we examined the distribution
of the polymorphism in an independent sample consisting
of patients with major depression in comparison to a fur-
ther sample of locally recruited healthy controls. In this
analysis, there was no association of any of the genetic
Healthy controls, original sample
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Table 1. Genotype and allele distributions for the A2457G polymorphism in the ABCG1 gene among patients with mood disorders, suicide
attempters and healthy controls
Subjects n Genotype distribution
A/A
n %
A/G
n %
G/G
n %
Allele frequency
A
n %
G
n %
97 24 24.7 44 45.4 29 29.9 92 47.4 102 52.6
Total Males 48 12 25.0 22 45.8 14 29.2 46 47.9 50 52.1
Females 49 12 24.5 22 44.9 15 30.6 46 46.9 52 53.1
Healthy controls, replication sample 92 15 16.3 51 55.4 26 28.3 81 44.0 103 56.0
Total Males 65 12 18.5 38 58.5 15 23.1 62 47.7 68 52.3
Females 27 3 11.1 13 48.2 11 40.7 19 35.2 35 64.8
Mood disorders, original sample 52 10 19.2 19 36.5 23 44.2 39 37.5 65 62.5
Total Males 17 1 5.9 7 41.2 9 52.9 9 26.5 25 73.5
Females 35 9 25.7 12 34.3 14 40.0 30 42.9 40 57.1
Mood disorders, replication sample 104 24 23.1 51 49.0 29 27.9 99 47.6 109 52.4
Total Males 25 7 28.0 12 48.0 6 24.0 26 52.0 24 48.0
Females 79 17 21.5 39 49.4 23 29.1 73 46.2 85 53.8
Suicide attempters 70 18 25.7 28 40.0 24 34.3 64 45.7 76 54.3
Total Males 26 6 23.1 9 34.6 11 42.3 21 40.4 31 59.6
Females 44 12 27.3 19 43.2 13 29.5 43 48.9 45 51.1
variants with major depression in males (p = 0.726 for
allele and p = 0.565 for genotype frequencies), females
(p = 0.210 for allele and p = 0.366 for genotype frequen-
cies) or in the total sample (p = 0.336 for allele and p =
0.394 for genotype frequencies). When combining both
groups of patients with affective disorders and comparing
them to the pooled data of healthy controls, there was no
association of any variant of the G2457A polymorphism
in the ABCG1 gene with affective disorders (both gen-
ders: p = 0.998 for allele and p = 0.692 for genotype fre-
quencies; males: p = 0.352 for allele and p = 0.482 for
genotype frequencies; females: p = 0.896 for allele and p =
0.630 for genotype frequencies). Moreover, there was no
association of any variant of the polymorphism with sui-
cidal behavior (p = 0.844 for allele and p = 1.0 for geno-
type frequencies).
Discussion
In contrast to the previous report by Nakamura et al.
[5], who found an association of the A allele and AA geno-
type of the G2457A polymorphism in the ABCG1 gene
with affective disorders in males, the G allele and GG
genotype frequencies tended to be higher in our first
group of males with affective disorders. In order to avoid
false-positive results, we attempted to reproduce these
findings in replication samples. In these samples, there
was no association with major depression. Moreover,
allele and genotype frequencies did not differ between
cases and controls when data from both studies were com-
bined. These findings might suggest that variations in the
ABCG1 gene do not contribute to the genetic susceptibili-
ty to affective disorders. Affective disorders are currently
conceptualized as etiologically heterogeneous, with indi-
viduals carrying probably different, although partially
overlapping, sets of susceptibility genes. It is possible that
the affective disorder groups used in this study do not
share identical susceptibility genes. The initial group con-
sists of inpatients with a severer course, and probably life-
time course of the illness, in comparison with the replica-
tion sample consisting of outpatients with a more re-
stricted range of affective symptoms (i.e. unipolar depres-
sion in most of the cases). Replication studies in larger
populations of patients are necessary in order to clarify
the role of ABCG1 in affective disorders. It is also possi-
ble that another gene located in the chromosomal region,
21q22.3, may turn out to be involved in the genetic vul-
ABCG1 and Affective Disorders Neuropsychobiology 2000;42(suppl 1):22–25 25
nerability to mood disorders. This is the first study to
investigate the role of the ABCG1 transporter in suicidal
behavior. Our results do not provide evidence that
ABCG1 transporter gene contributes to the genetic sus-
ceptibility for suicidal behavior.
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